Tags : Ravitchi

Horizon Pharma’s Ravitchi (Glycerol Phenylbutyrate) Receives FDA Approval for Expansion

Shots: The expansion approval of age range for ravicti is based on the study assessing safety, efficacy and PK in UCD infants patients aged ≤ 2mos. The study demonstrated safety and efficacy in children younger than two months, with stable ammonia levels relative to pre-study enrollment Ravitchi (glycerol phenylbutyrate) is an oral nitrogen binding agent liquid, indicated for chronic […]Read More